Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
Clinical trial NCT03789240 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03789240
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-22
- Primary completion
- 2025-09-24
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.